#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4421916	B	Inhibition of rat recombinant geranylgeranyltransferase type I expressed in Escherichia coli assessed as reduction in geranylgeranylation of RhoA incubated for 30 mins in presence of [3H]GGPP by scintillation counting assay relative to control	Rattus norvegicus	87	ALA4421722	assay format	Patent Bioactivity Data
2.	ALA4421917	F	Antiproliferative activity against human K562 cells assessed as inhibition of cell proliferation incubated for 72 hrs by CCK8 assay	Homo sapiens	27	ALA4421722	cell-based format	Patent Bioactivity Data
3.	ALA4421920	F	Antiproliferative activity against human Jurkat cells assessed as inhibition of cell proliferation incubated for 72 hrs by CCK8 assay	Homo sapiens	33	ALA4421722	cell-based format	Patent Bioactivity Data
4.	ALA4421921	F	Antiproliferative activity against human MCF7 cells assessed as inhibition of cell proliferation incubated for 6 days by CCK8 assay	Homo sapiens	8	ALA4421722	cell-based format	Patent Bioactivity Data
5.	ALA4421923	F	Antiproliferative activity against human BT474 cells assessed as inhibition of cell proliferation incubated for 72 hrs by CCK8 assay	Homo sapiens	7	ALA4421722	cell-based format	Patent Bioactivity Data
6.	ALA4421925	F	Antiproliferative activity against human MIAPaCa2 cells assessed as inhibition of cell proliferation incubated for 72 hrs by CCK8 assay	Homo sapiens	8	ALA4421722	cell-based format	Patent Bioactivity Data
7.	ALA4421926	F	Antiproliferative activity against human AsPC1 cells assessed as inhibition of cell proliferation incubated for 6 days by CCK8 assay	Homo sapiens	7	ALA4421722	cell-based format	Patent Bioactivity Data
8.	ALA4421927	F	Antiproliferative activity against human PANC1 cells assessed as inhibition of cell proliferation incubated for 72 hrs by CCK8 assay	Homo sapiens	7	ALA4421722	cell-based format	Patent Bioactivity Data
9.	ALA4421928	F	Antiproliferative activity against human Capan2 cells assessed as inhibition of cell proliferation incubated for 72 hrs by CCK8 assay	Homo sapiens	8	ALA4421722	cell-based format	Patent Bioactivity Data
10.	ALA4421929	F	Antiproliferative activity against human CFPAC-1 cells assessed as inhibition of cell proliferation incubated for 72 hrs by CCK8 assay	Homo sapiens	8	ALA4421722	cell-based format	Patent Bioactivity Data
11.	ALA4421931	B	Competitive inhibition of rat recombinant geranylgeranyltransferase type I expressed in Escherichia coli assessed as reduction in geranylgeranylation of RhoA incubated for 30 mins in presence of varying level of [3H]GGPP and fixed RhoA levels by scintillation counting assay relative to control	Rattus norvegicus	4	ALA4421722	assay format	Patent Bioactivity Data
12.	ALA4421951	F	Antiproliferative activity against human SEMK2 cells assessed as inhibition of cell proliferation incubated for 6 days by CCK8 assay	Homo sapiens	2	ALA4421722	cell-based format	Patent Bioactivity Data
13.	ALA4421952	F	Antiproliferative activity against human HPAC cells assessed as inhibition of cell proliferation incubated for 72 hrs by CCK8 assay	Homo sapiens	2	ALA4421722	cell-based format	Patent Bioactivity Data
14.	ALA4421953	F	Induction of cell cycle arrest in human K562 cells assessed as accumulation at G1 phase incubated for 48 hrs by flow cytometry	Homo sapiens	2	ALA4421722	cell-based format	Patent Bioactivity Data
15.	ALA4421954	F	Induction of cell cycle arrest in human K562 cells assessed as reduction in accumulation at S phase incubated for 48 hrs by flow cytometry	Homo sapiens	2	ALA4421722	cell-based format	Patent Bioactivity Data